Reckitt Benckiser Group plc (RBGLY)
- Previous Close
13.24 - Open
12.29 - Bid 12.29 x 321800
- Ask 12.31 x 40000
- Day's Range
12.22 - 12.30 - 52 Week Range
10.43 - 14.10 - Volume
70,825 - Avg. Volume
344,637 - Market Cap (intraday)
41.891B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
22.76 - EPS (TTM)
0.54 - Earnings Date Mar 6, 2025
- Forward Dividend & Yield 0.53 (3.98%)
- Ex-Dividend Date Apr 11, 2025
- 1y Target Est
16.04
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
www.reckitt.com37,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RBGLY
View More
Performance Overview: RBGLY
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RBGLY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RBGLY
View MoreValuation Measures
Market Cap
45.14B
Enterprise Value
55.70B
Trailing P/E
24.49
Forward P/E
15.31
PEG Ratio (5yr expected)
1.31
Price/Sales (ttm)
2.47
Price/Book (mrq)
5.08
Enterprise Value/Revenue
2.94
Enterprise Value/EBITDA
14.08
Financial Highlights
Profitability and Income Statement
Profit Margin
10.06%
Return on Assets (ttm)
8.22%
Return on Equity (ttm)
18.86%
Revenue (ttm)
14.17B
Net Income Avi to Common (ttm)
1.43B
Diluted EPS (ttm)
0.54
Balance Sheet and Cash Flow
Total Cash (mrq)
880M
Total Debt/Equity (mrq)
131.41%
Levered Free Cash Flow (ttm)
2.11B
Research Analysis: RBGLY
View MoreResearch Reports: RBGLY
View MoreReckitt Earnings: Productivity and Competitiveness Gains Lay Foundation for Accelerating Growth
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
RatingPrice TargetReckitt Has a Strong Portfolio of Core Brands and Is Undergoing a Promising Transformation Journey
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
RatingPrice TargetReckitt: Shares Rebound Strongly After Significant Win in Ongoing Premature Formula Litigation
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
RatingPrice TargetReckitt: Consensus Beat Sends Shares Higher Despite Anemic Hygiene Performance
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
RatingPrice Target